THE EFFECTIVENESS, IMMUNOGENICITY, AND SAFETY OF THE Escherichia Coli BASED BIVALENT HUMAN PAPILLOMAVIRUS (TYPES 16 AND 18) VACCINE PREVENTING CERVICAL CANCER: A Systematic Review. JIMKI 2025, 11 (3), 21-37. https://doi.org/10.53366/jimki.v11i3.795.